Navigation
Navigation
User login
Back to top
Home
MDS-RIGHT
Manifesto
News & events
Media centre
About MDS
Resources
Countries
Patient information
Patient organisations
Study groups
National haematology societies
Publications
Auto-immune manifestations
Biology and pathogenesis
Classification
Diagnostics
Epidemiology
General reviews
Guidelines and recommendations
Health economics
Monitoring
Patients' perspective
Prognostics / risk scores
Quality of Life
Response evaluation
Treatment
General management / supportive care
Hematopoietic cell transplantation
Hematopoietic growth factors
Hydroxy-Acetylhydroxylase (HDAC) inhibitors and other epigenetic therapy
Hypomethylating agents (HMA)
Immunomodulatory drugs
Immunosuppressive drugs
Intensive chemotherapy
Investigational drugs
Low dose chemotherapy
Red blood cell transfusions (iron chelation)
Supportive care
Treatment of thrombocytopenia
Clinical trials
Registries
Research tools
Research funders
Health authorities
Other stakeholders
Patient management
Articles
Contact information
Legal statements
Using our RSS feed
News & articles RSS feed
Login
Username
Password
Forgotten password
Website UI Version
1.13.1
Hydroxy-Acetylhydroxylase (HDAC) inhibitors and other epigenetic therapy
Publications - Treatment
Hydroxy-Acetylhydroxylase (HDAC) inhibitors and other epigenetic therapy
Search
in Title, Author & Year
Zotero errors and warning messages